Form 4: Oncology Institute CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Robert Ross Carter, CFO of Oncology Institute, sold shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- Robert Ross Carter, the Chief Financial Officer of Oncology Institute, Inc. (TOI), reported a transaction on January 6, 2025.
- Carter disposed of 258 shares of Class A Common Stock at a price of $0.335.
- The sale was executed to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
- Following the transaction, Carter beneficially owns 31,501 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document reports a routine transaction (sale of shares to cover taxes) by a company insider, which is neither particularly positive nor negative.
Industry Context
Form 4 filings are a routine part of the US stock market, and are required by the SEC to ensure transparency of trading by corporate insiders.
Stakeholder Impact
- The sale of shares by an insider could have a minor negative impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 01/06/2025 | Date of transaction: CFO Robert Ross Carter disposed of shares. |
| 01/07/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.